Drug
Palifermin
Palifermin: highest development phase Phase 3, developed by Swedish Orphan Biovitrum. 5 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Swedish Orphan Biovitrum
Trials
| Drug | Phase | Indication |
|---|---|---|
| palifermin NCT00109031 | Phase 3 | Cancer |
| palifermin NCT00101582 | Phase 3 | Mucositis |
| Palifermin NCT00094861 | Phase 2 | Dysphagia |
| palifermin NCT00540332 | Phase 1/2 | Head and Neck Cancer |
| Palifermin NCT01163097 | Phase 1 | Oral Mucositis |
Latest
No recent events.
Follow Palifermin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.